Table 1.
Characteristics and perioperative outcomes of the included studies
| Year of publication |
2012 |
2015 |
2016 |
2016 |
2016 |
2017 |
2018 |
2019 |
|---|---|---|---|---|---|---|---|---|
| Study | Matei et al. [4] | Pokorny et al. [18] | Martín Garzón et al. [19] | Martín Garzón et al. [19] | Pavan et al. [20] | Zhang et al. [21] | Johnson et al. [3] | Nestler et al. [22] |
| No. of patients | 35 | 67 | 79 | 76 | 130 | 32 | 12 | 35 |
| No. of surgeons | - | 2 | 1 | 1 | 3 or more | 2 | 2 | |
| Age (yr) | 65.5 | 69 | 69.5 | 64.5 | 67.4 | 71 | 70 | 70.9 |
| Mean operative time (min) | 186 | 97 | - | - | 150 | 274 | 157 | 182 |
| Estimate blood loss (mL) or Hemoglobin change | 121 mL | 200 mL | 390 mL | 535 mL | 250 mL | -2.5 g/dL | -5.4 % | -1.5 g/dL |
| Duration of Foley catheter indwelling (day) | 7.4 | 3 | 9.1 | 9.4 | 5 | 8 | 4 | 5 |
| Hospitalization period (day) | 3.17 | 4 | - | - | 5 | 8 | 4 | 5 |
| preoperative PSA (mg/dL) | 5.44 | 6.5 | 6.7 | 10 | 6.1 | 6.4 | ||
| Preoperative prostate volume (g) | 106.6 | 129 | 80.3 | 75.5 | 118.5 | 121.5 | 94.5 | |
| Resection volume (g) | 87.04 | 84 | - | - | 77 | 110 | 61.2 | 77 |
| Preoperative IPSS | 28 | 25 | 22.7 | 20.9 | 23 | - | - | 23 |
| Postoperative IPSS | 7 | 3 | 5.8 | 6.2 | 5 | - | - | - |
| Transfusion rate (%) | 0 | 1.5 | 6.3 | 6.3 | 9.4 | 3.3 | 9.4 | |
| Surgical route | Transvesical | - | Millin (retropubic) | Intrafascial | Trans and extraperitoneal | - | - | - |
| Major complication rate (%) | - | 4.5 | 3.9 | 1.2 | 2.3 | 3.1 | 7.5 | - |
| Participation center (single or multi) | Single | Single | Single | Single | Single | Single | Single | - |
| Comparable study | - | - | vs. LSP | vs. LSP | vs. LSP | vs. HoLEP | Learning curve | vs. OSP, ThuVEP |
| Cancer detection rate (%) | - | - | 5.06 | 26 | 0.8 | - | 11 | - |
IPSS, International Prostate symptom Score; LSP, laparoscopic simple prostatectomy; OSP, open simple prostatectomy; HoLEP, holmium laser enucleation of the prostate; ThuVEP, thulium vapoenucleation of the prostate.